Press Telebriefing: long COVID & ME

Share on facebook
Share on twitter
Share on email

When: Thursday, March 25, 12 p.m. PT / 3 p.m. ET 

Contact: Adriane Tillman, #MEAction, [email protected] 

MEDIA Advisory: A Panel of Experts to Explain How Long COVID Intersects with ME/CFS   

On March 25, #MEAction will host a telepresser featuring a panel of experts who are uniquely positioned to speak to how long COVID is being informed by the research on myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS).  

Long haulers are overwhelmingly reporting symptoms that resemble ME/CFS at six months, and researchers are expecting the number of people with ME/CFS to more than double during the pandemic, which follows the pattern of past viral outbreaks. Dr. Anthony Fauci has warned repeatedly of the risk for COVID-19 patients to develop ME/CFS. 

Our panel of experts knew this was coming, and have dedicated a large part of their careers preparing for this moment. Since the beginning of the pandemic, ME/CFS researchers and clinicians expected that a worldwide viral outbreak would lead to a massive surge in chronic illnesses, including ME/CFS. 

  • NINDS Clinical Director, Dr. Avindra Nath, MD, has launched two intramural studies at the NIH to investigate long COVID, which follows on the heels of the institute’s intramural work investigating ME/CFS. Both studies are showing overlapping findings and symptoms. 
  • Dr. Lucinda Bateman, MD, founder of the Bateman Horne Center, is seeing overlapping symptoms in both her long COVID and ME/CFS patients.
  • Dr. Anthony Komaroff, MD oversees the Columbia University – Center for Solutions for ME/CFS Long-COVID study with the Bateman Horne Center. He chaired the Neurology section of the NIH Conference on Post-COVID health complications this past December. In his Frontiers article exploring how past viral outbreaks have led to surges of chronic illness, he estimates COVID-19 will double the number of people with ME/CFS.
  • A long hauler and person with ME/CFS will share their experiences of getting a virus and not recovering.     

The pandemic has put a spotlight on the many fractures in our society, and long COVID has exposed the lack of disability support, persistent stigma and underinvestment in infection-triggered chronic illnesses like ME/CFS. 


  • Dr. Avindra Nath, MD., Intramural Clinical Director of the National Institute of Neurological Disorders and Stroke (NINDS)
  • Dr. Anthony Komaroff, MD, Simcox-Clifford-Higby Distinguished Professor of Medicine, Harvard Medical School, Senior Physician at Brigham and Women’s Hospital in Boston, and Editor-in-Chief of the Harvard Health Letter
  • Dr. Lucinda Bateman, MD, Founder and Medical Director of the Bateman Horne Center 
  • Long hauler, Jen, 53, former nurse
  • Person with ME, Ashanti Daniel, disabled RN


Myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) is a complex chronic disease that presents with symptoms in multiple body systems, and is predominately triggered by an infection. 

Chronic illness following viral outbreaks is not new, and has been well-documented to lead to ~12 percent rates of ME/CFS in subjects who contracted Epstein-Barr virus, Q Fever, and Ross River. A study on SARS showed that 27% of survivors met the criteria for CFS several years later. (See study links below.) 

Last December, a preprint study of long COVID was published in which 3,762 respondents from 56 countries reported their symptoms six months after contracting COVID-19. The main symptoms reported by long haulers resemble the defining symptoms of ME/CFS – fatigue, post-exertional malaise and cognitive dysfunction. 

The NIH has long neglected to invest in researching ME/CFS. It continues to remain the most underfunded disease in the NIH’s portfolio based on disease burden. It is imperative that the NIH fund ME/CFS research as part of its Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) initiatives. 

About: #MEAction is an international advocacy organization made up of people with ME/CFS, family members and allies. We are fighting for recognition, education, and research so that, one day, all people with ME will have support and access to compassionate and effective care. Learn more:


Read more on the connection between long COVID and ME/CFS:

Studies and articles on post-viral illness: 

Preprint survey on characterization of long COVID:  

Read about the disease burden and historic underinvestment of ME/CFS: 

Share on facebook
Share on twitter
Share on whatsapp
Share on google
Share on email

Leave a Comment

Your email address will not be published. Required fields are marked *

Latest News

Choose your top ten ME/CFS research priorities – UK survey launched

Take the survey The ME/CFS Priority Setting Partnership (PSP) is giving you the opportunity to define your top ten priorities for future ME/CFS research. In partnership with the James Lind Alliance, the ME/CFS Priority Setting Partnership is launching their second survey today. The research questions in this survey are based on over 5300 ideas submitted

Read More »

Statement from Forward-ME on NICE Roundtable

After NICE held its roundtable to discuss the new ME/CFS guideline, Forward-ME (which #MEAction UK is a member of) have produced the below statement. Clinician and Patient Support Confirmed for new NICE Guideline on ME/CFS. On Monday, Forward-ME and member charities attended a roundtable to review the new ‘NICE guideline on ME/CFS’ with representatives from

Read More »

Is NIH blowing another opportunity to advance ME/CFS research?

Be sure to attend the telebriefing by the Trans-NIH ME/CFS Working Group this Friday (10/22) at 3PM ET. The National Institutes of Health (NIH) has many questions to answer about its lack of tangible progress or strategic acceleration of medical research for people with ME. Read Our Questions for NIH ME/CFS research opportunity being missed

Read More »

Help keep our work going

We rely on donations from people like you to keep fighting for equality for people with ME.


Get actions alerts and news direct to your inbox

You can choose what you want to be kept up to date on.

Scroll to Top